To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The leader of the Triad’s ...

Profit outlook tops Wall Street estimates amid strong diagnostics demand Peer growth trends also benefiting Quest Diagnostics CEO Adam Schechter cites continued growth focus for 2026 Analyst estimates ...

Restructuring and other charges represent amounts incurred in connection with the elimination of redundant positions and facilities within the organization in connection with our LaunchPad initiatives ...

Good day, and thank you for standing by. Welcome to Labcorp's Fourth Quarter 2024 Conference Call [Operator Instructions]. Please be advised today's conference being recorded. I would now like to hand ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Thursday, Laboratory Corp (NYSE: LH) reported fourth-quarter 2024 adjusted earnings per share of $3.45, up from $3.30 a year ago, beating the consensus of $3.39. Sales increased 9.8% year-over-year to ...

Reports Q3 revenue $3.28B, consensus $3.26B. “Labcorp (LH) achieved strong performance in Diagnostics and Biopharma Laboratories, including robust organic growth in the third quarter,” said Adam ...

Labcorp CEO Adam Schechter on Tuesday urged Americans to be vaccinated against Covid-19 and told CNBC that recipients are not being advised to be tested for Covid antibodies afterward. "At the moment, ...